Neovasc Inc.

Neovasc Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™ for the treatment of refractory angina and the Tiara™ technology in development for the transcatheter treatment of mitral valve disease. To receive Neovasc updates via email, please register at: http://www.neovasc.com/register.

Company Details

Employees
28
Founded
-
Address
13700 Mayfield Place, Suite 2135, Richmond,b.c. V6v2e4,canada
Phone
604-270-4344
Email
in****@****asc.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Richmond, B.C.
Looking for a particular Neovasc Inc. employee's phone or email?

Neovasc Inc. Questions

News

Shockwave Medical to Acquire Neovasc - Yahoo Finance

Shockwave Medical to Acquire Neovasc Yahoo Finance

Shockwave Medical Announces Agreement to Acquire Neovasc - GlobeNewswire

Shockwave Medical Announces Agreement to Acquire Neovasc GlobeNewswire

Neovasc Files CE Mark for Tiara TA Transapical Mitral Valve Replacement System - Diagnostic and Interventional Cardiology

Neovasc Files CE Mark for Tiara TA Transapical Mitral Valve Replacement System Diagnostic and Interventional Cardiology

Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina - TCTMD.com

Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina TCTMD.com

Shockwave to pay $100M for Neovasc, adding refractory angina treatment to device pipeline - MedTech Dive

Shockwave to pay $100M for Neovasc, adding refractory angina treatment to device pipeline MedTech Dive

Shockwave Medical completes Neovasc acquisition - MassDevice

Shockwave Medical completes Neovasc acquisition MassDevice

No More Patent Drama Between Neovasc and Edwards? - Medical Device and Diagnostic industry

No More Patent Drama Between Neovasc and Edwards? Medical Device and Diagnostic industry

FDA panel recommends against approval of angina relief device - Healio

FDA panel recommends against approval of angina relief device Healio

Neovasc, an OPKO Investee, Receives FDA Conditional Approval to Initiate TIARA-I Trial in U.S.: A Multinational, Multicenter Early Feasibility Trial of the TiaraTM Transcatheter Mitral Valve - OPKO Health, Inc.

Neovasc, an OPKO Investee, Receives FDA Conditional Approval to Initiate TIARA-I Trial in U.S.: A Multinational, Multicenter Early Feasibility Trial of the TiaraTM Transcatheter Mitral Valve OPKO Health, Inc.

Shockwave Medical's heart disease business gets a jolt with $100M Neovasc buy - Fierce Biotech

Shockwave Medical's heart disease business gets a jolt with $100M Neovasc buy Fierce Biotech

Neovasc Receives CE Mark for Refractory Angina Treatment System - Diagnostic and Interventional Cardiology

Neovasc Receives CE Mark for Refractory Angina Treatment System Diagnostic and Interventional Cardiology

Shockwave Medical Announces Dan Puckett to Retire as CFO in 2024 - Yahoo Finance

Shockwave Medical Announces Dan Puckett to Retire as CFO in 2024 Yahoo Finance

Neovasc angina device fails to win FDA panel backing, stock tumbles 43% - MedTech Dive

Neovasc angina device fails to win FDA panel backing, stock tumbles 43% MedTech Dive

Shockwave Medical to acquire Neovasc for up to $147M - MassDevice

Shockwave Medical to acquire Neovasc for up to $147M MassDevice

Shockwave Medical Announces Agreement to Acquire Neovasc - Diagnostic and Interventional Cardiology

Shockwave Medical Announces Agreement to Acquire Neovasc Diagnostic and Interventional Cardiology

Shockwave Medical Publishes 2022 ESG Report - Yahoo Finance

Shockwave Medical Publishes 2022 ESG Report Yahoo Finance

Neovasc Reducer Improves Function in Patients With Refractory Angina - Diagnostic and Interventional Cardiology

Neovasc Reducer Improves Function in Patients With Refractory Angina Diagnostic and Interventional Cardiology

Neovasc Receives First U.S. Patent for its Tiara Transcatheter Mitral Valve Replacement Technology - Diagnostic and Interventional Cardiology

Neovasc Receives First U.S. Patent for its Tiara Transcatheter Mitral Valve Replacement Technology Diagnostic and Interventional Cardiology

Device to Treat Refractory Angina Featured in Live Case at TCT - Diagnostic and Interventional Cardiology

Device to Treat Refractory Angina Featured in Live Case at TCT Diagnostic and Interventional Cardiology

Shockwave Medical Debuts Enhanced Catheter at TCT 2023, Announces Clinical Research Validation - Diagnostic and Interventional Cardiology

Shockwave Medical Debuts Enhanced Catheter at TCT 2023, Announces Clinical Research Validation Diagnostic and Interventional Cardiology

Can Shockwave crack the code for FDA approval of its Reducer implant? - Medical Design & Outsourcing

Can Shockwave crack the code for FDA approval of its Reducer implant? Medical Design & Outsourcing

Neovasc Inc. (NASDAQ: NVCN) is a Stock Spotlight on 3/31 | User | minstercommunitypost.com - FinancialContent

Neovasc Inc. (NASDAQ: NVCN) is a Stock Spotlight on 3/31 | User | minstercommunitypost.com FinancialContent

Pinsent Masons paves way for Neovasc heart valve patent - JUVE Patent

Pinsent Masons paves way for Neovasc heart valve patent JUVE Patent

Neovasc refractory angina treatment faces FDA panel review - MedTech Dive

Neovasc refractory angina treatment faces FDA panel review MedTech Dive

Shockwave to acquire Neovasc for up to $120M - BioWorld MedTech

Shockwave to acquire Neovasc for up to $120M BioWorld MedTech

German Court Crowns Edwards with Shared Tiara Rights - Medical Device and Diagnostic industry

German Court Crowns Edwards with Shared Tiara Rights Medical Device and Diagnostic industry

Shockwave Medical To Buy Neovasc: Details (NVCN) - Pulse 2.0

Shockwave Medical To Buy Neovasc: Details (NVCN) Pulse 2.0

Neovasc pauses Tiara transfemoral mitral valve program, cuts workforce by 40% - BioWorld MedTech

Neovasc pauses Tiara transfemoral mitral valve program, cuts workforce by 40% BioWorld MedTech

Shockwave Medical Completes Deal for Neovasc - Medical Product Outsourcing

Shockwave Medical Completes Deal for Neovasc Medical Product Outsourcing

Neovasc files PMA for angina treatment - BioWorld MedTech

Neovasc files PMA for angina treatment BioWorld MedTech

Neovasc to seek CE Mark for Tiara transapical mitral valve repair device - MassDevice

Neovasc to seek CE Mark for Tiara transapical mitral valve repair device MassDevice

Boston Scientific closes $75m Neovasc deal - MassDevice

Boston Scientific closes $75m Neovasc deal MassDevice

Peregrine Ventures Sells 30 Percent Stake In Neovasc - NoCamels

Peregrine Ventures Sells 30 Percent Stake In Neovasc NoCamels

Vancouver’s Neovasc acquired for $135 million - Business in Vancouver

Vancouver’s Neovasc acquired for $135 million Business in Vancouver

Judge orders $21M in enhanced damages for trade secret theft - Massachusetts Lawyers Weekly

Judge orders $21M in enhanced damages for trade secret theft Massachusetts Lawyers Weekly

Shockwave Medical (NDAQ:SWAV) completes Neovasc (TSX:NVCN) acquisition | 2023-04-11 | Investing News - Stockhouse

Shockwave Medical (NDAQ:SWAV) completes Neovasc (TSX:NVCN) acquisition | 2023-04-11 | Investing News Stockhouse

Neovasc replaces long-time CEO - Business in Vancouver

Neovasc replaces long-time CEO Business in Vancouver

Edwards Lifesciences subsidiary CardiAQ Valve wins another $21m in Neovasc patent spat - MassDevice

Edwards Lifesciences subsidiary CardiAQ Valve wins another $21m in Neovasc patent spat MassDevice

Chris Clark - Business in Vancouver

Chris Clark Business in Vancouver

Top Neovasc Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant